Here’s whether Guardant Health, Inc. Common Stock (GH) is worth buying in 2026 —
based on weekly-updated price trend, RSI momentum, and return vs.
the S&P 500. Our current read: Bullish.
🟢
Bullish
Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+5.26% over 10 days); RSI 61 — healthy momentum range; strong 1-year return of +160.4%; 3-month momentum positive (+65.6%). Currently 11.0% off its 52-week high. Score: +7/7.
GH is in a confirmed uptrend, trading above both its 50-day ($149.58) and 200-day ($112.03) moving averages. An RSI of 60.6 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of +160.4% compares to +20.4% for SPY (beat the market by 140.1%).
$10,000 invested 1 year ago→ $26,045 today
vs. S&P 500 (SPY) — same period beat market by 140.1%
1-Year Price Chart
Daily candles
MA-50MA-200UpDown
Signal Check
✓Above 200-day MA ($112.03)
✓Above 50-day MA ($149.58)
✓RSI(14) neutral zone (30–70) — currently 60.6
✓Positive return (+160.4%)
!Within 10% of period high (−11.0%)
Period Range $157.21
$53.40$176.58
RSI (14) 60.6
0 · OversoldOverbought · 100
Key Metrics
Price$157.21
Period Return+160.4%
Period High$176.58
Period Low$53.40
Drawdown−11.0%
MA-50$149.58
MA-200$112.03
RSI (14)60.6
Avg Volume (30d)2.1M
vs. SPYbeat by 140.1%
Return Rank#76 of 1252
Trend Signals
Price is above the 200-day moving average ($112.03)
Price is above the 50-day moving average ($149.58)